T T-DETECT Trademark

Trademark Overview


On Friday, January 22, 2021, a trademark application was filed for T T-DETECT with the United States Patent and Trademark Office. The USPTO has given the T T-DETECT trademark a serial number of 90481362. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 11, 2023. This trademark is owned by Adaptive Biotechnologies Corp.. The T T-DETECT trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical assay kits comprised of diagnostic reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, autoimmune disease and infection; medical immunosequencing-based assay kits comprised of diagnostic reagents for medical use; medical immunosequencing-based assay kits comprised of medical grade reagents and sample plates for detecting cancer, autoimmune disease and infection

Medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services related to the treatment of persons; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services; providing medical immunosequencing-based testing for cancer, autoimmune disease and infection; consulting services in the field of medical immunosequencing-based testing.

Development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA scr...
t t-detect

General Information


Serial Number90481362
Word MarkT T-DETECT
Filing DateFriday, January 22, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 11, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 13, 2022

Trademark Statements


Description of MarkThe mark consists of a capitalized letter "T" in stylized form, underneath which is the word "T-Detect".
Goods and ServicesMedical assay kits comprised of diagnostic reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, autoimmune disease and infection; medical immunosequencing-based assay kits comprised of diagnostic reagents for medical use; medical immunosequencing-based assay kits comprised of medical grade reagents and sample plates for detecting cancer, autoimmune disease and infection
Goods and ServicesMedical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services related to the treatment of persons; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services; providing medical immunosequencing-based testing for cancer, autoimmune disease and infection; consulting services in the field of medical immunosequencing-based testing.
Goods and ServicesDevelopment of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immunedisorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; medical laboratory immunosequencing-based services for analysis of biological samples

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 23, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 3, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 3, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAdaptive Biotechnologies Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102

Party NameAdaptive Biotechnologies Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102

Trademark Events


Event DateEvent Description
Monday, September 11, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 11, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 3, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, November 3, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 3, 2022EXAMINERS AMENDMENT E-MAILED
Thursday, November 3, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, April 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 11, 2022NON-FINAL ACTION E-MAILED
Monday, April 11, 2022NON-FINAL ACTION WRITTEN
Tuesday, April 5, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, March 8, 2022WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, February 24, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 1, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 31, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 31, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 30, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 30, 2021NON-FINAL ACTION E-MAILED
Friday, July 30, 2021NON-FINAL ACTION WRITTEN
Tuesday, July 20, 2021ASSIGNED TO EXAMINER
Friday, April 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 26, 2021NEW APPLICATION ENTERED